| Edward J Prince, MD | |
|
1490 E Foremaster Dr Ste 150, St George, UT 84790-4495 | |
| (435) 628-9393 | |
| (435) 628-9382 |
| Full Name | Edward J Prince |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 1490 E Foremaster Dr Ste 150, St George, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659306975 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 35581 (Arizona) | Secondary |
| 207X00000X | Orthopaedic Surgery | 5820907-8905 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sun Tree Home Health, Llc | St george, UT | Home health agency |
| Dixie Home Rehab | St george, UT | Home health agency |
| Zion's Way Home Health | St george, UT | Home health agency |
| Dixie Regional Medical Center | St george, UT | Hospital |
| Kane County Hospital | Kanab, UT | Hospital |
| Page Hospital | Page, AZ | Hospital |
| Cedar City Hospital | Cedar city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Utah Clinic Pc | 7517868508 | 391 |
News Archive
The Netherlands' three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of MEUR 28 on innovative research targeted at bringing personalized medicine closer to reality.
A rarely used—and as yet largely unproven—approach to drug development has emerged as a significant tool in the effort to create high-impact new cancer drugs.
Health law advocates are concerned about low-income residents who are left out of health overhaul in states that are not expanding Medicaid. Meanwhile, in other states, the new enrollment in the joint federal-state program is strong.
The exhaust from diesel-fuelled vehicles, wood fires and coal-driven power stations contains small particles of soot that flow out into the atmosphere. The soot is a scourge for the climate but also for human health. Now for the first time, researchers have studied in detail how diesel soot gets stuck in the lungs. The results show that more than half of all inhaled soot particles remain in the body.
Millennium: The Takeda Oncology Company today announced data from clinical trials of four investigational compounds in solid tumors presented at the Annual Meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, June 4-8, 2010. These data include an oral presentation on MLN8237, the Company's selective Aurora A kinase inhibitor.
› Verified 1 days ago
| Entity Name | Central Utah Clinic Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093764805 PECOS PAC ID: 7517868508 Enrollment ID: O20040113000805 |
News Archive
The Netherlands' three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of MEUR 28 on innovative research targeted at bringing personalized medicine closer to reality.
A rarely used—and as yet largely unproven—approach to drug development has emerged as a significant tool in the effort to create high-impact new cancer drugs.
Health law advocates are concerned about low-income residents who are left out of health overhaul in states that are not expanding Medicaid. Meanwhile, in other states, the new enrollment in the joint federal-state program is strong.
The exhaust from diesel-fuelled vehicles, wood fires and coal-driven power stations contains small particles of soot that flow out into the atmosphere. The soot is a scourge for the climate but also for human health. Now for the first time, researchers have studied in detail how diesel soot gets stuck in the lungs. The results show that more than half of all inhaled soot particles remain in the body.
Millennium: The Takeda Oncology Company today announced data from clinical trials of four investigational compounds in solid tumors presented at the Annual Meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, June 4-8, 2010. These data include an oral presentation on MLN8237, the Company's selective Aurora A kinase inhibitor.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Edward J Prince, MD 1055 N 500 W, Attn: Credentialing, Provo, UT 84604-3305 Ph: (801) 354-8225 | Edward J Prince, MD 1490 E Foremaster Dr Ste 150, St George, UT 84790-4495 Ph: (435) 628-9393 |
News Archive
The Netherlands' three Top Institutes for life-science research (the BioMedical Materials program, the Center for Translational Molecular Medicine and Top Institute Pharma) today announced a joint investment of MEUR 28 on innovative research targeted at bringing personalized medicine closer to reality.
A rarely used—and as yet largely unproven—approach to drug development has emerged as a significant tool in the effort to create high-impact new cancer drugs.
Health law advocates are concerned about low-income residents who are left out of health overhaul in states that are not expanding Medicaid. Meanwhile, in other states, the new enrollment in the joint federal-state program is strong.
The exhaust from diesel-fuelled vehicles, wood fires and coal-driven power stations contains small particles of soot that flow out into the atmosphere. The soot is a scourge for the climate but also for human health. Now for the first time, researchers have studied in detail how diesel soot gets stuck in the lungs. The results show that more than half of all inhaled soot particles remain in the body.
Millennium: The Takeda Oncology Company today announced data from clinical trials of four investigational compounds in solid tumors presented at the Annual Meeting of the American Society of Clinical Oncology, held in Chicago, Illinois, June 4-8, 2010. These data include an oral presentation on MLN8237, the Company's selective Aurora A kinase inhibitor.
› Verified 1 days ago
Zachary Scott Jager, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 652 S Medical Center Dr Ste 120, St George, UT 84790 Phone: 435-251-3600 | |
Dr. Zachary Robert Leitze, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 652 S Medical Center Dr, Suite 120, St George, UT 84790 Phone: 435-628-4460 | |
Dr. Michael Anderson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1490 E Foremaster Dr, #150, St George, UT 84790 Phone: 435-628-9393 Fax: 435-628-9382 | |
Dr. Aaron Michael O'brien, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1490 E Foremaster Dr, Ste 150, St George, UT 84790 Phone: 435-628-9393 Fax: 435-628-9382 | |
Dr. Todd Richard Parry, M.D Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1490 E Foremaster Dr Ste 150, St George, UT 84790 Phone: 435-628-9393 Fax: 435-628-9382 | |
Dirk L Slade, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 652 S Medical Center Dr, Ste 400, St George, UT 84790 Phone: 435-251-2650 Fax: 435-251-2668 | |
Andrew Kenneth Ence, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2825 E Mall Dr, St George, UT 84790 Phone: 435-628-9393 |